Apatinib Clinical Trials
22 recruitingDrug
Phase 217Phase 33Not Applicable1Phase 11
Showing 1–20 of 22 trials
Recruiting
Phase 2
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
Breast CancerBreast NeoplasmHER2-negative Breast Cancer+7 more
Fudan University716 enrolled1 locationNCT05582499
Recruiting
Phase 2
Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for Unresectable Biliary Tract Cancer
Biliary Tract Cancer
Air Force Military Medical University, China124 enrolled1 locationNCT07569679
Recruiting
Phase 2
Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer
AdebrelimabAdenocarcinoma of GE JunctionAdenocarcinoma of Stomach
Beijing Friendship Hospital49 enrolled1 locationNCT07353684
Recruiting
Phase 2
PD1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer
Advanced Gastric CancerSHR1701
The First Affiliated Hospital of Zhengzhou University78 enrolled1 locationNCT07294664
Recruiting
Phase 3
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
Gastric CancerGastroesophageal-junction Cancer
AstraZeneca572 enrolled186 locationsNCT06346392
Recruiting
Phase 2
A Study of Yttrium [90Y] Microsphere Injection in Combination With Targeted Immunotherapy in the Treatment of HCC
HCC
GrandPharma (China) Co., Ltd.120 enrolled3 locationsNCT07334483
Recruiting
Phase 2
ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC
HCC - Hepatocellular Carcinoma
Peking Union Medical College Hospital300 enrolled1 locationNCT07157969
Recruiting
Phase 2
A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study
Malignant Neoplasms of Digestive Organs
LaNova Medicines Zhejiang Co., Ltd.276 enrolled1 locationNCT05934331
Recruiting
Not Applicable
Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Nanjing Tianyinshan Hospital300 enrolled1 locationNCT06893887
Recruiting
Phase 2
Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma
Adrenal Cortical CancerAdrenal Cortical CarcinomaAdrenal Cancer
West China Hospital28 enrolled1 locationNCT06831175
Recruiting
Phase 2
Adebrelimab Combined with Apatinib and Gemcitabine and Cisplatin (GP) First-line Treatment for Unresectable Biliary Tract Carcinoma
Unresectable Biliary Tract Carcinoma
Henan Cancer Hospital63 enrolled1 locationNCT06749730
Recruiting
Phase 2
Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis
HER2-negative Breast Cancer Brain Metastases
Beijing 302 Hospital30 enrolled1 locationNCT06418594
Recruiting
Phase 2
Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer
Locally Advanced Thyroid Gland Carcinoma
West China Hospital75 enrolled1 locationNCT06482086
Recruiting
Phase 2
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
Breast CancerBreast NeoplasmHER2-negative Breast Cancer+2 more
Fudan University620 enrolled1 locationNCT05594095
Recruiting
Phase 3
Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer
Advanced Breast CancerHR+/HER2- Breast Cancer
Fudan University184 enrolled1 locationNCT06447623
Recruiting
Phase 1
A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary Tract Malignancies
Biliary Tract Malignancies
First Affiliated Hospital of Fujian Medical University35 enrolled1 locationNCT06181032
Recruiting
Phase 2
Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Apatinib and HAIC
Intrahepatic Cholangiocarcinoma
Lei ZHAO20 enrolled1 locationNCT06296563
Recruiting
Phase 2
Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma
Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University32 enrolled1 locationNCT06339619
Recruiting
Phase 2
Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer
Breast Cancer Metastatic
Fudan University145 enrolled1 locationNCT05759572
Recruiting
Phase 2
KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade
Digestive System Cancers
Peking University Cancer Hospital & Institute39 enrolled1 locationNCT06099821